pRESS RELEASES

nEWS ABOUT US

Cantourage partners with FarmaGrowers to bring the first South African medical cannabis to Germany

European medical cannabis leaders Cantourage and South Africa-based farming enterprise FarmaGrowers have today confirmed an agreement to supply South African medical cannabis dried flower products to German pharmacies. The agreement means that Germany’s growing number of currently more than 128,000 patients will now have access to South African medical cannabis dried flower products for the first time.

Read More »

Halo Collective’s Bophelo Bioscience & Wellness Signs Distribution Agreement with Cantourage GmbH for Rapidly Growing European Market

Halo Collective Inc. (“Halo”) (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN) today announced that its wholly-owned subsidiary, Bophelo Bioscience & Wellness (Pty) Ltd. (“Bophelo”), has signed a processing and distribution agreement with Cantourage GmbH, (“Cantourage”) one of Europe’s leading providers of medical cannabis. With this agreement,

Read More »

Cantourage in Media

We are the experts

“I think Europe is moving in the right direction” – Interview with Cantourage CEO Philip Schetter

As the negotiations after the federal election are ongoing, we still don’t know who will succeed Angela Merkel, the outgoing German chancellor. In the last 17 years, Germany has introduced some changes that helped patients who needed medical cannabis. However, Europe, as a whole, is still miles behind North America. What’s going on in Germany right now, and what could the solution be? Is a legal recreational market a possibility? How could a new scheme, the so-called “Fast Track Acess” be a game changer? We asked Cantourage CEO, Philip Schetter.

Read More »

We’re a speaking at Cannabis Business Europe 2021

One of our funders, Patrick Hoffmann, will be a guest speaker during the Cannabis Business Europe 2021 Conference in Frankfurt. His panel is titled “Decreasing Complexity in the European Medical Cannabis Market” and it will cover the following topics:   Fast Track Access to EU

Read More »

wHO ARE WE?

fACTS ABOUT US

Cantourage GmbH is a Berlin-based cannabis company that has already established itself as one of the leading European companies in the medical cannabis sector. Founded in 2019, the company enables producers from across the world to bring their product into the European market more quickly and cheaply, without having to deal with complex and lengthy regulatory processes. Cantourage is run by industry experts and pioneers of the European medical cannabis sector and offers products in all relevant market segments: dried flowers, extracts and Dronabinol

Products & Services

Cantourage offers products in all relevant market segments: dried flowers, extracts and Dronabinol. Through its platform, Cantourage helps non-EU producers to tackle the complexity of adhering to EU-GMP guidelines, by easing market access and offering a completely new and enhanced way of distributing their products. Cantourage offers services and support to its platform partners from product imports and transformation to warehousing and logistics to Sales and Marketing.

Fact Sheet

Company Founded
2019
Headquarters
Berlin / Germany
Number of employees
25
Funding
Series B
Founders
Dr. Florian Holzapfel,
Norman Ruchholtz
Patrick Hoffmann
Management:
Norman Ruchholtz CEO
Philip Schetter, Co-CEO

dOWNLOAD

Marketing aSSETS

Questions?

Press contact

If you are a journalist and have questions about our company, operations or plans for expansion please get in touch with our press agency.

 

Press contacts
Kekst CNC
cantourage@kekstcnc.com
Roland Leithaeuser
+49 162 2074 592